« Back to Record
Citation APA

de Azambuja, E., Paesmans, M., Beauduin, M., Vindevoghel, A., Cornez, N., Finet, C., Ries, F., Closon-Dejardin, M. T., Kerger, J., Gobert, P., Focan, C., Tagnon, A., Dolci, S., Nogaret, J.-M., Di Leo, A., & Piccart-Gebhart, M. (2009). Long-term benefit of high-dose epirubicin in adjuvant chemotherapy for node-positive breast cancer: 15-year efficacy results of the Belgian multicentre study. Journal of clinical oncology, 27(5), 720-725. doi:10.1200/JCO.2008.17.2155


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/52343

de Azambuja, E., Paesmans, M., Beauduin, M., Vindevoghel, A., Cornez, N., Finet, C., Ries, F., Closon-Dejardin, M. T., Kerger, J., Gobert, P., Focan, C., Tagnon, A., Dolci, S., Nogaret, J.-M., Di Leo, A., & Piccart-Gebhart, M. (2009). Long-term benefit of high-dose epirubicin in adjuvant chemotherapy for node-positive breast cancer: 15-year efficacy results of the Belgian multicentre study. Journal of clinical oncology, 27(5), 720-725. doi:10.1200/JCO.2008.17.2155